E-safety netting (E-SN) toolkit Not Applicable
Conditions
Interventions
The researchers will recruit 60 general practices who are not currently using the E-SN toolkit, and randomise them in clusters (groups) of 10. Each cluster will have the E-SN toolkit turned on at a d
Sponsors
University of Oxford
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: GP practices will be eligible for inclusion under the following conditions: 1. They are actively contributing to the RCGP Research and Surveillance Centre database 2. They use the EMIS electronic health record system 3. They have data available for the previous 24 months Within the participating practices, the researchers will seek to extract data from adult patients (aged over 18 years)
Exclusion criteria
Exclusion criteria: 1. GP practices who are already using the E-SN toolkit will not be eligible for the study 2. The researchers will not extract data from any patient under 18, or from any patient who has opted out of data sharing for research purposes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary care interval for cancer diagnoses measured as the time between the first recorded symptom of cancer and referral to secondary cancer care, during inactive and active E-SN phases | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Proportion of cancers diagnosed after emergency presentation measured during inactive and active E-SN phases 2. Recorded new diagnoses in those who have a template activated, measured by cancer site and stage, and by non-cancer diagnosis, during the active E-SN stage 3. Total time to diagnosis measured from 1st recorded symptom to definitive diagnosis for all cancer diagnoses during the inactive and active E-SN phases and all diagnoses with template activation during the active E-SN phase 4. Number of GP consultations/patient between first record of symptom and cancer referral, measured during the inactive and active E-SN phase 5. Rates of patients completing direct access cancer investigations measured during the inactive and active E-SN phase 6. Rates of patients referred measured as 2-week wait, urgent, and routine, during the inactive and active E-SN phase 7. Timing of template activation within the primary care interval (from first symptom to referral) measured during the active E-SN phase 8. Template activation rate amongst consulting patients, both total and stratified by individual GP, measured during the active E-SN phase 9. The proportion of diary entries completed measured during the active E-SN phase 10. The reason for template activation measured based on 20 high-level READ codes during the active E-SN phase 11. Symptoms leading to direct access to investigations measured during the active E-SN phase 12. Recorded vague symptoms in the template measured during the active E-SN phase 13. Demographic details of patients with activated templates measured during the active E-SN phase 14. GP type completing template (e.g. partner, locum, trainee) measured during the active E-SN phase 15. Diagnostic codes in patients with activated templates measured during the active E-SN phase | — |
Countries
England, United Kingdom
Contacts
Public ContactSusannah Fleming
Outcome results
None listed